These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24920903)

  • 1. Mesoporous magnesium silicate-incorporated poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) bioactive composite beneficial to osteoblast behaviors.
    Niu Y; Dong W; Guo H; Deng Y; Guo L; An X; He D; Wei J; Li M
    Int J Nanomedicine; 2014; 9():2665-75. PubMed ID: 24920903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue engineering scaffolds of mesoporous magnesium silicate and poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) composite.
    He D; Dong W; Tang S; Wei J; Liu Z; Gu X; Li M; Guo H; Niu Y
    J Mater Sci Mater Med; 2014 Jun; 25(6):1415-24. PubMed ID: 24595904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinoptilolite/PCL-PEG-PCL composite scaffolds for bone tissue engineering applications.
    Pazarçeviren E; Erdemli Ö; Keskin D; Tezcaner A
    J Biomater Appl; 2017 Mar; 31(8):1148-1168. PubMed ID: 27881642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid freeform fabrication and in-vitro response of osteoblast cells of mPEG-PCL-mPEG bone scaffolds.
    Jiang CP; Chen YY; Hsieh MF; Lee HM
    Biomed Microdevices; 2013 Apr; 15(2):369-79. PubMed ID: 23324877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoporosity improved water absorption, in vitro degradability, mineralization, osteoblast responses and drug release of poly(butylene succinate)-based composite scaffolds containing nanoporous magnesium silicate compared with magnesium silicate.
    Wu Z; Li Q; Pan Y; Yao Y; Tang S; Su J; Shin JW; Wei J; Zhao J
    Int J Nanomedicine; 2017; 12():3637-3651. PubMed ID: 28553104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradability, cytocompatibility, and osteogenesis of porous scaffolds of nanobredigite and PCL-PEG-PCL composite.
    Hou J; Fan D; Zhao L; Yu B; Su J; Wei J; Shin JW
    Int J Nanomedicine; 2016; 11():3545-55. PubMed ID: 27555774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocalcium-deficient hydroxyapatite-poly (e-caprolactone)-polyethylene glycol-poly (e-caprolactone) composite scaffolds.
    Wang Z; Li M; Yu B; Cao L; Yang Q; Su J
    Int J Nanomedicine; 2012; 7():3123-31. PubMed ID: 22848159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of bioactive mesoporous wollastonite - Polycaprolactone composite scaffold.
    Wei J; Chen F; Shin JW; Hong H; Dai C; Su J; Liu C
    Biomaterials; 2009 Feb; 30(6):1080-8. PubMed ID: 19019424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of hydrophilicity, biocompatibility and biodegradability of poly(ε-caprolactone) electrospun nanofiber scaffolds using poly(ethylene glycol) and poly(L-lactide-co-ε-caprolactone-co-glycolide) as additives for soft tissue engineering.
    Arbade GK; Srivastava J; Tripathi V; Lenka N; Patro TU
    J Biomater Sci Polym Ed; 2020 Sep; 31(13):1648-1670. PubMed ID: 32402230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced biocompatibility and osteogenic potential of mesoporous magnesium silicate/polycaprolactone/wheat protein composite scaffolds.
    Kang YG; Wei J; Shin JW; Wu YR; Su J; Park YS; Shin JW
    Int J Nanomedicine; 2018; 13():1107-1117. PubMed ID: 29520139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-printed scaffolds of mesoporous bioglass/gliadin/polycaprolactone ternary composite for enhancement of compressive strength, degradability, cell responses and new bone tissue ingrowth.
    Zhang Y; Yu W; Ba Z; Cui S; Wei J; Li H
    Int J Nanomedicine; 2018; 13():5433-5447. PubMed ID: 30271139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of bioactive calcium silicate and poly(epsilon-caprolactone) nanocomposite for bone tissue regeneration.
    Wei J; Heo SJ; Liu C; Kim DH; Kim SE; Hyun YT; Shin JW; Shin JW
    J Biomed Mater Res A; 2009 Sep; 90(3):702-12. PubMed ID: 18563819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of physical, chemical and cellular responses to nano- and micro-sized calcium silicate/poly(epsilon-caprolactone) bioactive composites.
    Wei J; Heo SJ; Kim DH; Kim SE; Hyun YT; Shin JW
    J R Soc Interface; 2008 Jun; 5(23):617-30. PubMed ID: 17999948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a bone substitute material based on alpha-tricalcium phosphate scaffold coated with carbonate apatite/poly-epsilon-caprolactone.
    Bang LT; Ramesh S; Purbolaksono J; Long BD; Chandran H; Ramesh S; Othman R
    Biomed Mater; 2015 Jul; 10(4):045011. PubMed ID: 26225725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and properties of nano-hydroxyapatite/PCL-PEG-PCL composite membranes for tissue engineering applications.
    Fu SZ; Wang XH; Guo G; Shi S; Fan M; Liang H; Luo F; Qian ZY
    J Biomed Mater Res B Appl Biomater; 2011 Apr; 97(1):74-83. PubMed ID: 21290585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melt electrohydrodynamic 3D printed poly (ε-caprolactone)/polyethylene glycol/roxithromycin scaffold as a potential anti-infective implant in bone repair.
    Bai J; Wang H; Gao W; Liang F; Wang Z; Zhou Y; Lan X; Chen X; Cai N; Huang W; Tang Y
    Int J Pharm; 2020 Feb; 576():118941. PubMed ID: 31881261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication and characterization of chitosan/OGP coated porous poly(ε-caprolactone) scaffold for bone tissue engineering.
    Cui Z; Lin L; Si J; Luo Y; Wang Q; Lin Y; Wang X; Chen W
    J Biomater Sci Polym Ed; 2017 Jun; 28(9):826-845. PubMed ID: 28278041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced osteogenic activity by MC3T3-E1 pre-osteoblasts on chemically surface-modified poly(ε-caprolactone) 3D-printed scaffolds compared to RGD immobilized scaffolds.
    Zamani Y; Mohammadi J; Amoabediny G; Visscher DO; Helder MN; Zandieh-Doulabi B; Klein-Nulend J
    Biomed Mater; 2018 Nov; 14(1):015008. PubMed ID: 30421722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.